Wellthy Therapeutics Acquired
Wellthy Therapeutics is Asia's leading virtual chronic disease management company. Wellthy's solutions combine behavioral science and technology to deliver personalized digital therapies for chronic conditions including type 2 diabetes, hypertension, heart failure and chronic kidney disease. Note: founder attribution varies by source — some name only Abhishek Shah and Prayat Shah as co-founders (2015); others (per the company's own founders…
Wellthy Therapeutics: Funding Rounds
| Date | Round | Amount | Investors | Source |
|---|---|---|---|---|
| 15 Jun 2023 | Undisclosed | Undisclosed | Beyond Next Ventures | source |
| 13 Apr 2020 | Pre-Series A | $4 Mn (Rs 30 Cr) for 16% stake | Saama Capital | source |
| 19 Feb 2019 | Corporate Round | Rs 10.5 Cr ($1.5 Mn) for 11.71% stake | Cipla | source |
| 5 Mar 2018 | Seed | Rs 13.5 Cr ($2.1 Mn) | Beenext Ventures Currae Healthtech Fund GrowX Ventures IIFL Select Equity Fund Manipal Education & Medical Group | source |
Acquisitions
| Date | Acquirer | Acquired | Amount | Source |
|---|---|---|---|---|
| 13 Feb 2024 | TruDoc | Wellthy Therapeutics | Undisclosed | source |
Recent Signals
-
11 May 2023 · regulatory
Wellthy completes FDA 21 CFR Part 820/11 and HIPAA certification, expands into the US source -
11 Oct 2019 · ma-strategic
Wellthy joins Bayer G4A digital health partnership program, only South Asian company in Berlin cohort source -
28 Nov 2018 · ma-strategic
Roche Diabetes Care India partners with Wellthy for AI-based Accu-Chek coaching bundle source
News on Wellthy Therapeutics
No coverage of Wellthy Therapeutics linked yet.
L Litmus · by Lapaas
Got an idea like this one? Validate it with the same 9-block framework, free.
Start Free ValidationFAQs on Wellthy Therapeutics
Who founded Wellthy Therapeutics?
Wellthy Therapeutics was founded by Abhishek Shah, Prayat Shah, Maaz Shaikh, Mayuresh Joshi in 2015.
How much funding has Wellthy Therapeutics raised?
Wellthy Therapeutics has raised $7.6 Mn across 4 tracked funding round(s), most recently on 2023-06-15. Figures are compiled from cited public sources.
Who are the investors in Wellthy Therapeutics?
Investors in Wellthy Therapeutics include Beyond Next Ventures, Saama Capital, Cipla.
What does Wellthy Therapeutics do?
Wellthy Therapeutics is Asia's leading virtual chronic disease management company. Wellthy's solutions combine behavioral science and technology to deliver personalized digital therapies for chronic conditions including type 2 diabetes, hypertension, heart failure and chronic kidney disease. Note: founder attribution varies by source — some name…
Where is Wellthy Therapeutics headquartered?
Wellthy Therapeutics is headquartered in Mumbai, Maharashtra, India.
What is Wellthy Therapeutics's business model?
Wellthy Therapeutics's core value proposition centers on Clinically-validated digital therapies, AI-powered personal health coach, Regulatory-certified SaMD platform, Proven patient reach and impact.
How does Wellthy Therapeutics make money?
Wellthy Therapeutics's cited revenue streams include B2B2C revenue share with enterprise partners, Co-packaging deals with pharma brands, Platform licensing to payors & life-science enterprises.